PSS43 - DUPILUMAB IMPROVES ABSENTEEISM IN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS COMPARED WITH PLACEBO IN PHASE 3 LIBERTY AD SOLO STUDIES

Authors :: Q. Chen
Zhen Chen
M S de Bruin-Weller
Christine Taniou
J. Msihid
Laurent Eckert
Abhijit Gadkari
G. Bégo-Le Bagousse
Ana B. Rossi
Marius Ardeleanu
Source :: Value in Health. 21:S430
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Moderate to severe
medicine.medical_specialty
business.industry
Health Policy
Public Health, Environmental and Occupational Health
medicine
Absenteeism
Atopic dermatitis
Placebo
business
medicine.disease
Dermatology
Dupilumab

Full Text Access

Tools